SCHEDULE OF SUPPLEMENTAL CASH FLOW INFORMATION (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Supplemental Cash Flow Elements [Abstract]
Cash paid for interest		$ 185,000
Termination of right of use lease asset	(744,000)
Termination of right of use lease liability	744,000
Shares received for loan origination fee	(3,000,000)
Shares received for prepaid loan interest	(2,440,000)
Acquisition of APB net assets	38,765,000
Common A Shares issued for prepaid marketing services		210,000
Common A Shares issued for Impact BioMedical		3,132,000
Non-controlling interest related to Impact BioMedical		3,910,000
Series A Preferred Shares issued for Impact BioMedical		35,187,000
Notes receivable settled for assets in lieu of cash		$ 838,000